TOP 20 BEST SELLING DRUGS IN 2018

Question 1

Made by Amgen, a cardiovascular drug, lowers LDL

Answer 1

REPATHA (Evolocumab)

126% increase

Question 2

Made by Amgen, used for acute lymphoblastic leukemia (ALL)

Answer 2

BLINCYTO (Blinatumomab)

52% increase

Question 3

Made by Amgen, used as a monoclonal antibody for osteoporosis

Answer 3

PROLIA (Denosumab)

20% increase

Question 4

GSK’s best-selling HIV drugs

Answer 4

Trivicay (Dolutegravir) and Triumeq (Abacavir)

Question 5

GSK product, inhaler for asthma and COPD

Answer 5

ELLIPTA (Umeclidinium)

Question 6

GSK product, used for asthma

Answer 6

NUCALA (Dupilumab)

Question 7

Gilead products used to tx Hepa C

Answer 7

HARVONI (Ledipasvir)

EPCLUSA (Sofosbuvir and Velpatasvir)

Question 8

Gilead product used to tx and prevent HIV infections

Answer 8

TRUVADA (Emtricitabine and Tenofovir)

Question 9

AbbVie has recently announced that ______________, one of their most anticipated drugs in development that will be used to treat moderate to severe atopic dermatitis

Answer 9

Upadacitinib

Question 10

current bestselling drug in the world (2018)

Answer 10

Humira (adalimumab)

Question 11

one of today’s leading cancer drugs, made by AbbVie

Answer 11

Imbruvica (Ibrutinib)

Question 12

Multiple sclerosis treatment made by Novartis

Answer 12

Gilenya (Fingolimod)

Question 13

Sanofi’s three best-selling drugs (LLA)

Answer 13

Lantus (Insulin glargine) - insulin injection for diabetes

Lovenox (Enoxaparin) - anticoagulant to prevent blood clots

Aubagio (Terflunomide) - one-daily pill to treat a form of multiple sclerosis

Question 14

World’s top three cancer drugs:

Answer 14

Herceptin (Trastuzumab)
Avastin (Bevacizumab)
Rituxan (Rituximab)

Question 15

tops the global prescription-drug list of 2017

Answer 15

Humira (Adalimumab)

Question 16

It is indicated in the treatment of autoimmune diseases and moderate to severe active rheumatoid arthritis.

Answer 16

Humira (Adalimumab)

Question 17

ranks second in the global prescription-drug list of 2017 and achieved annual revenue growth of 62.97%

Answer 17

Eylea (Aflibercept)

Question 18

It is produced by Bayer (Germany) and Regeneron Pharmaceuticals (U.S.).

Answer 18

Eylea (Aflibercept)

Question 19

It was approved by the U.S. FDA for use in retinal indications and continues to be the market-leading brand in anti-VEGF therapy segment in the United States.

Answer 19

Eylea (Aflibercept)

Question 20

produced by Celgene (U.S.)

Answer 20

Revlimid (Lenalidomide)

Question 21

It is indicated in the treatment of multiple myloma and patent is set to expire in 2027.

Answer 21

Revlimid (Lenalidomide)

Question 22

Biogen and Roche co-markets the product indicated in the treatment of cancer.

Answer 22

Rituxan (Rituximab, MabThera)

Question 23

It is co-marketed by Amgen Inc. in the U.S. and Pfizer Inc. in Europe.

Answer 23

Enbrel (Etanercept)

Question 24

It is another drug indicated for autoimmune diseases including rheumatoid arthritis, psoriasis, and other inflammatory conditions.

Answer 24

Enbrel (Etanercept)

Question 25

product manufactured by Roche, and is primarily used in treatment of breast and gastric cancer

Answer 25

Herceptin (Trastuzumab)

Question 26

leading anticoagulant with sales grown up by whooping 121.55%, to reach global revenue of USD 7.4 billion in 2017

Answer 26

Eliquis (Apixaban)

Question 27

It is produced by Bristol-Myers Squibb (U.S.) and Pfizer (U.S.), and is primarily used in treatment of atrial fibrillation and Deep Vein Thrombosis (DVT).

Answer 27

Eliquis (Apixaban)

Question 28

Sales continued to grow strongly in global market, especially in China, after drug received the approval for the lung cancer indication.

Answer 28

Avastin (Bevacizumab)

Question 29

manufactured by Roche and is primarily used for treating advanced colorectal, breast, lung, kidney, cervical, and ovarian cancer, and relapsed glioblastoma

Answer 29

Avastin (Bevacizumab)

Question 30

It is indicated for autoimmune diseases and produced by Johnson & Johnson (U.S.) and Merck & Co. (U.S.).

Answer 30

Remicade (Infliximab)

Question 31

anti-coagulant was manufactured by Bayer (Germany) and Johnson & Johnson (U.S.)

Answer 31

Xarelto (Rivaroxaban)

Question 32

aids in the reduction of the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE)

Answer 32

Xarelto (Rivaroxaban)

Question 33

It is used for the treatment of type 2 diabetes.

Answer 33

Januvia/Janumet (Sitagliptin)

Question 34

a longer-lasting insulin analogue is produced by Sanofi (France)

Answer 34

Lantus (Insulin glargine)

Question 35

It is a fully human monoclonal antibody that has been approved and continues to be used as an anti-cancer treatment and manufactured by Bristol-Myers Squibb.

Answer 35

Opdivo (Nivolumab)

Question 36

It is a recombinant human granulocyte-colony stimulating factor (G-CSF) manufactured by Amgen (U.S.) and Kyowa Hakko Kirin (Japan).

Answer 36

Neulasta/ Peglasta and Neupogen / Gran (Pegfilgrastim and Filgrastim)

Question 37

It is an antiepileptic from Pfizer Inc.

Answer 37

Lyrica (Pregabalin)

Question 38

This product from Gilead Sciences is indicated in the treatment of HCV/HIV infection.

Answer 38

Harvoni (Ledipasvir/Sofosbuvir)

Question 39

manufactured by GSK (U.K.) and indicated in treatment of asthma and maintenance treatment of COPD

Answer 39

Advair/Seretide (Fluticasone and Salmeterol)

Question 40

it is manufactured by Biogen (U.S.). This drug is used for treating multiple sclerosis.

Answer 40

Tecfidera (Dimethyl fumarate)

Question 41

It is manufactured by Johnson & Johnson (U.S.). This drug is used for treating Plaque psoriasis.

Answer 41

Stelara (Ustekinumab)